(19)
(11) EP 4 499 115 A1

(12)

(43) Date of publication:
05.02.2025 Bulletin 2025/06

(21) Application number: 23781522.0

(22) Date of filing: 23.03.2023
(51) International Patent Classification (IPC): 
A61K 33/22(2006.01)
A61K 36/67(2006.01)
 A61K 36/9066(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 33/22; A61P 35/00; A61K 31/4525; A61K 31/12
 
C-Sets:
  1. A61K 31/4525, A61K 2300/00;
  2. A61K 31/12, A61K 2300/00;
  3. A61K 33/22, A61K 2300/00;
(86) International application number:
PCT/TR2023/050276
(87) International publication number:
WO 2023/191746 (05.10.2023 Gazette 2023/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 31.03.2022 TR 202205058

(71) Applicant: Yeditepe Universitesi
Atasehir/Istanbul (TR)

(72) Inventors:
  • SAHIN, Fikrettin
    34755 Ata ehir/ stanbul (TR)
  • OMEROGLU ULU, Zehra
    34755 Ata ehir/ stanbul (TR)
  • BOLAT, Zeynep Busra
    34303 Küçükçekmece/ stanbul (TR)
  • DEGIRMENCI, Nurdan Sena
    34118 stanbul (TR)

(74) Representative: Sevinç, Cenk 
Grup Ofis Marka Patent A.S. Atatürk Bulvari, 211/11 Kavaklidere
06680 Ankara
06680 Ankara (TR)

   


(54) AN ANTI-CANCER FORMULATION COMPRISING SODIUM PENTABORATE, CURCUMIN AND PIPERINE FOR USE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA